Lenvatinib 10 mg Oral Capsule
RxNorm 1604345
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1604345 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lenvatinib 10 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Lenvatinib 10 mg Oral Capsule
(Atom ID: 6833593)
Synonym (SY):
Lenvatinib (as lenvatinib mesilate) 10 mg oral capsule
(Atom ID: 12421327)
Designated preferred name (PT):
Lenvatinib (as lenvatinib mesylate) 10 mg oral capsule
(Atom ID: 12421329)
Synonym (SY):
Lenvatinib 10 mg (as lenvatinib mesylate 12.25 mg) Oral Capsule
(Atom ID: 12425261)
Prescribable Name (PSN):
Lenvatinib 10 mg Oral Capsule
(Atom ID: 6837605)
Full form of descriptor (FN):
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 12421836)
Patient Education
Lenvatinib
Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine. Lenvatinib is also used along with everolimus (Afinitor, Zortress) to treat renal cell carcinoma (RCC, a type of cancer that begins in the kidney) in people who have previously received treatment with another chemotherapy medication. Lenvatinib is also used to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Lenvatinib is also used along with pembrolizumab (Keytruda) to treat a certain type of cancer of the endometrium (lining of the uterus) that has spread to other parts of the body or worsened during or after treatment with chemotherapy medications or that cannot be treated with surgery or radiation therapy. Lenvatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
